CYTOMEGALOVIRUS-SERONEGATIVE BLOOD COMPONENTS FOR THE PREVENTION OF PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION - CONSIDERATIONS FOR BLOOD-BANKS

被引:53
作者
BOWDEN, RA
SAYERS, M
GLEAVES, CA
BANAJI, M
NEWTON, B
MEYERS, JD
机构
[1] UNIV WASHINGTON,SCH MED,DEPT PEDIAT & MED,SEATTLE,WA 98195
[2] PUGET SOUND BLOOD CTR,SEATTLE,WA 98104
关键词
D O I
10.1046/j.1537-2995.1987.27688071699.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:478 / 481
页数:4
相关论文
共 12 条
[1]   COMPARISON OF A LATEX AGGLUTINATION-TEST WITH 5 OTHER METHODS FOR DETERMINING THE PRESENCE OF ANTIBODY AGAINST CYTOMEGALO-VIRUS [J].
BECKWITH, DG ;
HALSTEAD, DC ;
ALPAUGH, K ;
SCHWEDER, A ;
BLOUNTFRONEFIELD, DA ;
TOTH, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) :328-331
[2]  
BENSINGER WI, IN PRESS PROGR TRANS, V3
[3]   CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION [J].
BOWDEN, RA ;
SAYERS, M ;
FLOURNOY, N ;
NEWTON, B ;
BANAJI, M ;
THOMAS, ED ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) :1006-1010
[4]   TRANSMISSION AND ACTIVATION OF CYTOMEGALOVIRUS WITH BLOOD-TRANSFUSION - MOUSE MODEL [J].
CHEUNG, KS ;
LANG, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (05) :841-845
[5]  
CHOU D, 1986, NEW ENGL J MED, V314, P1418
[6]   RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION AFTER HUMAN MARROW TRANSPLANTATION [J].
MEYERS, JD ;
FLOURNOY, N ;
THOMAS, ED .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :478-488
[7]  
MEYERS JD, 1985, CURRENT CLIN TOPICS, P261
[8]   INFECTIONS DUE TO HERPESVIRUSES IN CARDIAC TRANSPLANT RECIPIENTS - ROLE OF THE DONOR HEART AND IMMUNOSUPPRESSIVE THERAPY [J].
PREIKSAITIS, JK ;
ROSNO, S ;
GRUMET, C ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06) :974-981
[9]   IMPACT OF CYTOMEGALOVIRUS TESTING ON BLOOD COLLECTION FACILITIES [J].
SILVERGLEID, AJ ;
KOTT, TJ .
VOX SANGUINIS, 1983, 44 (02) :102-105
[10]  
VERDONCK LF, 1985, TRANSPLANTATION, V39, P455